Alnylam Pharmaceuticals (GB:0HD2)
LSE:0HD2

Alnylam Pharma (0HD2) Technical Analysis

0 Followers

Summary of all the Indicators

Summary
Neutral
8Bullish
5Neutral
9Bearish
Oscillators
Buy
4Bullish
5Neutral
1Bearish
Moving Averages
Sell
4Bullish
0Neutral
8Bearish
Alnylam Pharmaceuticals’s (0HD2) Moving Averages Convergence Divergence (MACD) indicator is -3.41, suggesting Alnylam Pharmaceuticals is a Buy.
Alnylam Pharmaceuticals’s (0HD2) 20-Day exponential moving average is 193.47, while Alnylam Pharmaceuticals’s (0HD2) share price is $193.265, making it a Sell.
Alnylam Pharmaceuticals’s (0HD2) 50-Day exponential moving average is 197.67, while Alnylam Pharmaceuticals’s (0HD2) share price is $193.265, making it a Sell.

Alnylam Pharma (0HD2) Pivot Points

Jun 06, 2023, 03:13 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
181.35
182.91
186.03
187.59
190.72
192.28
195.40
Fibonacci
182.91
184.70
185.80
187.59
189.38
190.49
192.28

Alnylam Pharma (0HD2) Moving Averages

Jun 06, 2023, 03:13 AM
Period
Simple
Exponential
MA5
188.25Buy
189.69Buy
MA10
189.40Buy
190.56Buy
MA20
196.25Sell
193.47Sell
MA50
197.34Sell
197.67Sell
MA100
205.23Sell
201.16Sell
MA200
209.40Sell
198.21Sell
Alnylam Pharmaceuticals’s (0HD2) 10-Day exponential moving average is 190.56, while Alnylam Pharmaceuticals’s (0HD2) share price is $193.265, making it a Buy.
Alnylam Pharmaceuticals’s (0HD2) 100-Day exponential moving average is 201.16, while Alnylam Pharmaceuticals’s (0HD2) share price is $193.265, making it a Sell.
Alnylam Pharmaceuticals’s (0HD2) stock price is $193.265 and Alnylam Pharmaceuticals’s (0HD2) 50-day simple moving average is 197.34, creating a Sell signal.
Alnylam Pharmaceuticals’s (0HD2) stock price is $193.265 and Alnylam Pharmaceuticals’s (0HD2) 100-day simple moving average is 205.23, creating a Sell signal.
Alnylam Pharmaceuticals’s (0HD2) stock price is $193.265 and Alnylam Pharmaceuticals’s (0HD2) 200-day simple moving average is 209.40, creating a Sell signal.

Alnylam Pharma (0HD2) Technical Indicators

Jun 06, 2023, 03:13 AM
Name
Value
Action
RSI (14)
48.08
Neutral
STOCH (9,6)
55.07
Neutral
STOCHRSI (14)
24.06
Neutral
MACD (12,26)
-3.41
Buy
ADX (14)
17.85
Buy
Williams %R
-59.83
Buy
CCI (14)
-29.68
Neutral
ATR (14)
3.56
-
Ultimate Oscillator
51.41
Neutral
ROC
-7.03
Sell
Alnylam Pharmaceuticals’s (0HD2) Relative Strength Index (RSI) is 48.08, creating a Neutral signal.
Alnylam Pharmaceuticals’s (0HD2) Trend Strength Indicator (ADX) is 17.85, creating a Buy signal.
Alnylam Pharmaceuticals’s (0HD2) Commodity Channel Index (CCI) is -29.68, creating a Neutral signal.
Alnylam Pharmaceuticals’s (0HD2) Price Rate of Change (ROC) is -7.03, creating a Sell signal.

FAQ

Is 0HD2 a Buy, Hold, or Sell?
Based on 0HD2’s technical indicators, 0HD2 is a Hold.
    What is 0HD2’s RSI (14)?
    0HD2’s RSI (14) is 48.08, which suggests 0HD2 is a Neutral.
      What is 0HD2’s MACD?
      0HD2’s MACD is -3.41, which suggests 0HD2 is a Buy.
        What is 0HD2’s 5-day moving average?
        0HD2’s 5-day moving average is 188.25, which suggests 0HD2 is a Buy.
          What is 0HD2’s 20-day moving average?
          0HD2 20-day moving average is 196.25, which suggests 0HD2 is a Sell.
            What is 0HD2’s 50-day moving average?
            0HD2’s 50-day moving average is 197.34, which suggests 0HD2 is a Sell.
              What is 0HD2’s 200-day moving average?
              0HD2’s 200-day moving average is 209.40, which suggests 0HD2 is a Sell.
                What is 0HD2’s Williams % R (14)?
                0HD2’s Williams % R (14) is -59.83, which suggests 0HD2 is a Buy.
                  What is 0HD2’s CCI (14)?
                  0HD2’s CCI (14) is -29.68, which suggests 0HD2 is a Neutral.

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis